METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Clinical trials for METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stall advanced cancers
Disease control Recruiting nowThis early-phase trial tests a combination of two drugs—temozolomide and M1774—in people with advanced solid tumors that have spread. Temozolomide damages cancer cell DNA, while M1774 blocks enzymes that help cancer grow. The goal is to find the best dose and see if the combo can…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental combo targets Tough-to-Treat colorectal cancer
Disease control Recruiting nowThis early-phase trial is testing whether combining two drugs—abemaciclib and 5-fluorouracil—is safe and tolerable for people with advanced colorectal cancer that has spread and stopped responding to standard treatments. About 39 participants will receive the combination to find …
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New immunotherapy cocktail takes on stubborn colorectal cancer
Disease control Recruiting nowThis early-phase trial is testing whether combining two immunotherapy drugs—nadunolimab and toripalimab—can help people with metastatic colorectal cancer that no longer responds to chemotherapy. The study will enroll 24 participants and first check for safety, then measure how ma…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC